WO2002057210A1 - Compositions stabilisees d'acide o-iodoxybenzoïque et leur procede de preparation - Google Patents

Compositions stabilisees d'acide o-iodoxybenzoïque et leur procede de preparation Download PDF

Info

Publication number
WO2002057210A1
WO2002057210A1 PCT/FR2002/000189 FR0200189W WO02057210A1 WO 2002057210 A1 WO2002057210 A1 WO 2002057210A1 FR 0200189 W FR0200189 W FR 0200189W WO 02057210 A1 WO02057210 A1 WO 02057210A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
stabilizing agent
mixtures
composition
iodoxybenzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2002/000189
Other languages
English (en)
French (fr)
Inventor
Dominique Depernet
Bruno Francois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Simafex SA
Original Assignee
Simafex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simafex SA filed Critical Simafex SA
Priority to AT02711994T priority Critical patent/ATE292613T1/de
Priority to DE60203595T priority patent/DE60203595T2/de
Priority to EP02711994A priority patent/EP1351917B1/fr
Priority to JP2002557892A priority patent/JP4332347B2/ja
Publication of WO2002057210A1 publication Critical patent/WO2002057210A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives

Definitions

  • the invention relates to stabilized compositions of o-iodoxybenzoic acid, or IBX, of formula
  • This hypervalent iodine derivative is the precursor of 1, 1, 1 -triacetoxy-1, 1 - d ⁇ hydro-1, 2-benzodioxol-3 (1 H) -one or periodinane of Dess-Martin, of formula
  • IBX can be prepared by oxidation of 2-iodobenzoic acid, in particular by KBrO 3 in sulfuric acid, a conventional process which has been improved several times, or by Oxone®, consisting of 2KHSO 5 .KHSO 4 .K 2 SO, as described in J. Org. Chem. 1999, 64, 4537-4538. The authors of this recent article confirm that the IBX obtained is a crystalline, white solid, which even explodes very pure.
  • the present invention relates to stabilized compositions of o-iodoxybenzoic acid which contain per 1 mole of o-iodoxybenzoic acid from 0.5 to 4 moles of a stabilizing agent chosen from
  • n is between 8 and 20 and preferably equal to 14 or
  • R represents H, CH 3 , COOH or their mixtures
  • compositions in which there are from 1 to 2.5 moles of stabilizing agent per mole of o-iodoxybenzoic acid, and better still from 1.8 to 2.2 moles, in order to ensure maximum stabilization without increase costs excessively.
  • acids of formula II preferred are benzoic, toluic, isophthalic and terephthalic acids, and among them of melting points above 200 C C such as isophthalic and terephthalic acid, temperature generally accepted as being that at which the IBX spontaneously explodes.
  • mixtures of benzoic acid or o-toluic acid or one of their mixtures on the one hand and isophthalic acid or terephthalic acid or one of their mixtures on the other hand for good reason from 25 to 75% by mole of the monoacid in the mixture and better from 45 to 55% give stabilized compositions which do not explode under the action of an impact or heat.
  • iodoxybenzoic acid compositions containing, as stabilizing agent, one or more compounds of formula II.
  • compositions based on stabilizing agent of formula I it is preferable in the compositions based on stabilizing agent of formula I to also introduce an agent of formula II and preference is given to mixtures of a part of stearic or palmitic acid or of one of their mixtures, widely used acids , and on the other hand terephthalic acid or isophthalic acid or a mixture thereof, in an amount of 25 to 75 mol% of fatty acid in the mixture.
  • the invention also relates to the process for preparing the compositions of the invention either from already isolated IBX or during the synthesis of IBX.
  • a solution or suspension in water is made of the alkaline salts, particularly sodium, of the acids constituting the composition, and then acidified to total insolubilization of the composition.
  • the stabilizing agents of formula I or II it is also possible to introduce a suitable quantity of one of the stabilizing agents of formula I or II, one of its alkaline salts or one of their mixtures into the medium in which the IBX is prepared, preferably in whole or partly from the start of the reaction, if the stabilizing agent is not broken down in this reaction medium.
  • the stabilizing agent is a mixture, one of the constituents may be added during the reaction and the other before the isolation of the IBX.
  • Those skilled in the art will be able, during a few preliminary tests, to determine the relative proportions of the stabilizing agent (s) and of the IBX as well as the modes of introduction of these agents, taking into account their possible reactivities and their relative solubilities in the media. reaction and precipitation.
  • the concentration of IBX in the compositions obtained was determined by assay with sodium thiosulfate, iodine released during the oxidation of Kl by the IBX present in the composition (oxidimetric test).
  • a composition is obtained which by heating gives a thick gray smoke but no orange flame.
  • 10 g of stearic acid are added to a suspension of 10 g of IBX in 60 ml of water before introducing dropwise 8 ml of 10N aqueous NaOH solution to salify the acids.
  • the heterogeneous medium is then acidified by adding 8 ml of an aqueous HCl solution at 33% before the isolation of the solid phase by filtration.
  • the composition obtained after washing with 30 ml of water and drying does not explode with heat.
  • Example 6 32 g of 2-iodobenzoic acid and 32 g of stearic acid are introduced into a solution of 1117 g of Oxone and 490 ml of water. After 2 hours at 70 ° C the medium is treated as above; the isolated composition generally does not explode with heat.
  • the same proportions of reagents are used as in the previous example, but benzoic acid and isophthalic acid are not introduced until after oxidation during the cooling of the medium, around 35 ° C.
  • the composition isolated by filtration is then homogenized. It is suspended in 4100 ml of water and 440 ml of aqueous 10N NaOH solution are added; the solution obtained at pH 7 is then acidified to 78 ° C by slow addition of 440 ml of an aqueous solution of hydrochloric acid at 33%.
  • the composition isolated after filtration, washing with 500 ml of water and drying under vacuum contains 45%) by weight of IBX (oxydimetry). It is shock resistant and does not explode on heating.
  • Example 8 The procedure is as in Example 8 but replacing the benzoic acid with a molar equivalent of stearic acid. A non-explosive composition is thus obtained which contains 38% by weight of IBX.
  • Example 10 15 minutes, 30.6 g of the composition of Example 10 to a solution of 4.7 g of 3-pyridylmethanol in 70 ml of dimethylsulfoxide and the medium is stirred for 2 hours before pouring it onto 150 ml of and 60 ml of ethyl acetate. After neutralization of the aqueous phase and separation of the precipitate, the organic phase is separated and brought to dryness. 4.2 g of the expected 3-pyridyl carboxaldehyde are obtained (conformal NMR).
  • menthone is obtained with L-menthol with 87% yield.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PCT/FR2002/000189 2001-01-19 2002-01-17 Compositions stabilisees d'acide o-iodoxybenzoïque et leur procede de preparation Ceased WO2002057210A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT02711994T ATE292613T1 (de) 2001-01-19 2002-01-17 Stabilisierte o- iodoxybenzoesäurezusammensetzungen und verfahren zu ihrer herstellung
DE60203595T DE60203595T2 (de) 2001-01-19 2002-01-17 Stabilisierte o-iodoxybenzoesäurezusammensetzungen und verfahren zu ihrer herstellung
EP02711994A EP1351917B1 (fr) 2001-01-19 2002-01-17 Compositions stabilisees d'acide o-iodoxybenzoique et leur procede de preparation
JP2002557892A JP4332347B2 (ja) 2001-01-19 2002-01-17 安定化o−ヨードキシ安息香酸組成物および製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100759A FR2819808B1 (fr) 2001-01-19 2001-01-19 Compositions stabilisees d'acide o-iodoxybenzoique et leur procede de preparation
FR01/00759 2001-01-19

Publications (1)

Publication Number Publication Date
WO2002057210A1 true WO2002057210A1 (fr) 2002-07-25

Family

ID=8859040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/000189 Ceased WO2002057210A1 (fr) 2001-01-19 2002-01-17 Compositions stabilisees d'acide o-iodoxybenzoïque et leur procede de preparation

Country Status (9)

Country Link
US (1) US6462227B2 (https=)
EP (1) EP1351917B1 (https=)
JP (1) JP4332347B2 (https=)
AT (1) ATE292613T1 (https=)
DE (1) DE60203595T2 (https=)
ES (1) ES2240717T3 (https=)
FR (1) FR2819808B1 (https=)
PT (1) PT1351917E (https=)
WO (1) WO2002057210A1 (https=)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007149305A3 (en) * 2006-06-22 2008-02-14 Wyeth Corp Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx)
US20120245323A1 (en) * 2009-12-11 2012-09-27 Contipro Pharma A.S. Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
US9434791B2 (en) 2009-12-11 2016-09-06 Contipro Pharma A.S. Method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof
US9492586B2 (en) 2012-02-28 2016-11-15 Contipro Biotech S.R.O. Derivatives of hyaluronic acid capable of forming hydrogels
US9522966B2 (en) 2012-08-08 2016-12-20 Contipro Biotech S.R.O. Hyaluronic acid derivative, method of preparation thereof, method of modification thereof and use thereof
CN107055741A (zh) * 2017-04-26 2017-08-18 成都科衡环保技术有限公司 一种高盐有机废水中难生物降解物质的处理剂及制备方法
US9999678B2 (en) 2012-11-27 2018-06-19 Contipro A.S. C6-C18-acylated derivative of hyaluronic acid and method of preparation thereof
US10023658B2 (en) 2014-03-11 2018-07-17 Contipro A.S. Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof
CN109535437A (zh) * 2018-12-30 2019-03-29 太原理工大学 一种以盐酸为调节剂极浓体系下合成高比表面MIL-100Cr的方法
US10414832B2 (en) 2015-06-26 2019-09-17 Contipro A.S Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10618984B2 (en) 2016-06-27 2020-04-14 Contipro A.S. Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof
US10759878B2 (en) 2015-06-15 2020-09-01 Contipro A.S. Method of crosslinking of polysaccharides using photoremovable protecting groups

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153373A1 (it) * 2015-09-03 2017-03-03 Dipharma Francis Srl Addotti stabili dell?acido 2-iodossibenzoico
CN109081826B (zh) * 2018-09-30 2020-03-27 上海再启生物技术有限公司 氧化剂ibx的制备方法
CN109053679B (zh) * 2018-09-30 2020-05-19 上海再启生物技术有限公司 戴斯马丁氧化剂的制备方法
WO2020130081A1 (ja) * 2018-12-21 2020-06-25 学校法人立命館 2-ヨードソ安息香酸類の製造方法
CN113185495A (zh) * 2020-12-28 2021-07-30 和德化学(苏州)有限公司 一种固体超强酸催化制备戴斯马丁试剂的工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2566592A (en) * 1950-07-01 1951-09-04 Smith Kline French Lab Stabilized iodoxy benzoic compounds and the method of producing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2566592A (en) * 1950-07-01 1951-09-04 Smith Kline French Lab Stabilized iodoxy benzoic compounds and the method of producing

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007149305A3 (en) * 2006-06-22 2008-02-14 Wyeth Corp Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx)
US20120245323A1 (en) * 2009-12-11 2012-09-27 Contipro Pharma A.S. Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
US9403918B2 (en) * 2009-12-11 2016-08-02 Contipro Pharma A.S. Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
US9434791B2 (en) 2009-12-11 2016-09-06 Contipro Pharma A.S. Method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof
US9492586B2 (en) 2012-02-28 2016-11-15 Contipro Biotech S.R.O. Derivatives of hyaluronic acid capable of forming hydrogels
US9522966B2 (en) 2012-08-08 2016-12-20 Contipro Biotech S.R.O. Hyaluronic acid derivative, method of preparation thereof, method of modification thereof and use thereof
US9999678B2 (en) 2012-11-27 2018-06-19 Contipro A.S. C6-C18-acylated derivative of hyaluronic acid and method of preparation thereof
US10023658B2 (en) 2014-03-11 2018-07-17 Contipro A.S. Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof
US10759878B2 (en) 2015-06-15 2020-09-01 Contipro A.S. Method of crosslinking of polysaccharides using photoremovable protecting groups
US10414832B2 (en) 2015-06-26 2019-09-17 Contipro A.S Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
US10618984B2 (en) 2016-06-27 2020-04-14 Contipro A.S. Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof
CN107055741A (zh) * 2017-04-26 2017-08-18 成都科衡环保技术有限公司 一种高盐有机废水中难生物降解物质的处理剂及制备方法
CN109535437A (zh) * 2018-12-30 2019-03-29 太原理工大学 一种以盐酸为调节剂极浓体系下合成高比表面MIL-100Cr的方法
CN109535437B (zh) * 2018-12-30 2021-09-07 太原理工大学 一种以盐酸为调节剂极浓体系下合成高比表面MIL-100Cr的方法

Also Published As

Publication number Publication date
ATE292613T1 (de) 2005-04-15
DE60203595D1 (de) 2005-05-12
US6462227B2 (en) 2002-10-08
EP1351917B1 (fr) 2005-04-06
PT1351917E (pt) 2005-08-31
JP2004523524A (ja) 2004-08-05
US20020107416A1 (en) 2002-08-08
EP1351917A1 (fr) 2003-10-15
DE60203595T2 (de) 2005-11-03
JP4332347B2 (ja) 2009-09-16
FR2819808B1 (fr) 2003-04-18
ES2240717T3 (es) 2005-10-16
FR2819808A1 (fr) 2002-07-26

Similar Documents

Publication Publication Date Title
EP1351917B1 (fr) Compositions stabilisees d'acide o-iodoxybenzoique et leur procede de preparation
EP0581980B1 (fr) Dérivés de l'acide quinique 3- et/ou 4-substitués et procédé de préparation de dérivés de l'acide quinique 3- et/ou 4-substitués
FR2474498A1 (fr) Derives de bis-moranoline et leur utilisation pour inhiber l'augmentation de sucre dans le sang
EP0303545B1 (fr) Procédé pour la préparation de phényléthanolaminotétralines
JPH0578277A (ja) 3,3,3−トリフルオロ乳酸の製造方法及び光学純度の向上法
JPH01186844A (ja) 3−(4’−ブロモビフェニル)−3−ヒドロキシ−4−フェニル酪酸エチルエステルの製造方法
EP0497065B1 (fr) Procédé industriel de préparation de dérivés phosphoniques de vinblastine
FR2518542A1 (fr) Dipeptides comportant un residu methionine et ayant un effet de protection pour le foie
CA2689466A1 (fr) Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
CH474465A (fr) Procédé pour la préparation d'une dihydroxy-dicétone
EP0184572A1 (fr) Procédé de préparation d'acides alpha-hydroxy-alcanoiques
EP0671375A1 (fr) Nouveau procédé de préparation de l'alcool 2,6-bis(trifluorométhyl)benzylique
BE517315A (https=)
FR2653127A1 (fr) Procede pour la preparation de 12-oxocholanates.
FR2653129A1 (fr) Procede pour la preparation de 7-oxocholanates.
BE557074A (https=)
FR2653126A1 (fr) Procede pour la preparation de diacetoxycholanates.
BE531443A (https=)
BE517764A (https=)
CH304382A (fr) Procédé de préparation d'acétate de 3,5,7,9(11),22-ergostapentaen-3-ol.
BE892860A (fr) N-(1-phenylethyl)-n-(3,3-diphenylpropyl)-hydroxylamines et procede pour leur preparation
CH639640A5 (en) Anilinotropone derivatives and their use for their anti-inflammatory and analgesic activities
CH635837A5 (fr) Procede de preparation de derives du thiophene et du furanne et derives obtenus par ce procede.
FR2668487A1 (fr) Procede economique de reduction de la zearalenone en zearalanol.
BE896093A (fr) Procede d'obtention d'alpha-chloronitroso-alcanes dimeres et alpha-chloronitroso-alcanes dimeres obtenus par ledit procede

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002711994

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002557892

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002711994

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002711994

Country of ref document: EP